Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Therapeutic Advances in Psychopharmacology|August 16, 2021
Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDAMichael P Hengartner, Martin PlöderlThe International Journal of Risk & Safety in Medicine|August 16, 2021
Suicidality and other severe psychiatric events with duloxetine: Re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgiaMichael P Hengartner, Martin PlöderlBMC Psychiatry|September 4, 2019
Guidelines for the pharmacological acute treatment of major depression: conflicts with current evidence as demonstrated with the German S3-guidelinesMartin Plöderl, Michael P HengartnerBMJ Evidence-Based Medicine|February 17, 2021
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depressionMichael P Hengartner, Martin PlöderlEuropean Journal of Public Health|November 25, 2020
Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates?Simone Amendola, Martin Plöderl, Michael P HengartnerCrisis|February 14, 2024
Suicide Rates and Prescription of AntidepressantsSimone Amendola, Martin Plöderl, Michael P HengartnerPlos One|February 27, 2020
Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trialsMichael P Hengartner, Janus C Jakobsen, Anders Sørensen, et al.Epidemiology and Psychiatric Sciences|August 23, 2019
Antidepressant withdrawal - the tide is finally turningMichael P Hengartner, James Davies, John ReadJournal of Epidemiology and Community Health|March 9, 2021
Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studiesMichael P Hengartner, Simone Amendola, Jakob A Kaminski, et al.Journal of Clinical Epidemiology|August 27, 2025
Large responses to antidepressants or methodological artifacts? A secondary analysis of STAR*D, a single-arm, open-label, non-industry antidepressant trialColin Xu, Florian Naudet, Thomas T Kim, et al.Pageof 27